Skip to Content

GG 771 (Glipizide 5 mg)

Pill imprint GG 771 has been identified as Glipizide 5 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glipizide 5 mg GG 771
Glipizide 5 mg GG 771  Front
Glipizide 5 mg GG 771  Back
Glipizide 5 mg GG 771  Front
Glipizide 5 mg GG 771  Back
Glipizide 5 mg GG 771
Glipizide
Imprint:
GG 771
Strength:
5 mg
Color:
White
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-1452
Inactive Ingredients:
microcrystalline cellulose
croscarmellose sodium
lactose monohydrate
magnesium stearate
silicon dioxide
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-6124 Major Pharmaceuticals
00832-0491 Upsher-Smith Laboratories Inc.
54569-3841 A-S Medication Solutions, LLC (repackager)
66267-0100 Nucare Pharmaceuticals Inc (repackager)
67544-0302 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide